307 related articles for article (PubMed ID: 12396620)
1. PEGylation of E1-deleted adenovirus vectors allows significant gene expression on readministration to liver.
Croyle MA; Chirmule N; Zhang Y; Wilson JM
Hum Gene Ther; 2002 Oct; 13(15):1887-900. PubMed ID: 12396620
[TBL] [Abstract][Full Text] [Related]
2. "Stealth" adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung.
Croyle MA; Chirmule N; Zhang Y; Wilson JM
J Virol; 2001 May; 75(10):4792-801. PubMed ID: 11312351
[TBL] [Abstract][Full Text] [Related]
3. Porcine adenoviral vectors evade preexisting humoral immunity to adenoviruses and efficiently infect both human and murine cells in culture.
Bangari DS; Mittal SK
Virus Res; 2004 Oct; 105(2):127-36. PubMed ID: 15351486
[TBL] [Abstract][Full Text] [Related]
4. Persistence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient (nu/nu) mice.
Zsengeller ZK; Wert SE; Hull WM; Hu X; Yei S; Trapnell BC; Whitsett JA
Hum Gene Ther; 1995 Apr; 6(4):457-67. PubMed ID: 7612702
[TBL] [Abstract][Full Text] [Related]
5. PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo.
O'Riordan CR; Lachapelle A; Delgado C; Parkes V; Wadsworth SC; Smith AE; Francis GE
Hum Gene Ther; 1999 May; 10(8):1349-58. PubMed ID: 10365665
[TBL] [Abstract][Full Text] [Related]
6. Nondepleting anti-CD4 antibody treatment prolongs lung-directed E1-deleted adenovirus-mediated gene expression in rats.
Lei D; Lehmann M; Shellito JE; Nelson S; Siegling A; Volk HD; Kolls JK
Hum Gene Ther; 1996 Dec; 7(18):2273-9. PubMed ID: 8953318
[TBL] [Abstract][Full Text] [Related]
7. Reduced toxicity, attenuated immunogenicity and efficient mediation of human p53 gene expression in vivo by an adenovirus vector with deleted E1-E3 and inactivated E4 by GAL4-TATA promoter replacement.
Ji L; Bouvet M; Price RE; Roth JA; Fang B
Gene Ther; 1999 Mar; 6(3):393-402. PubMed ID: 10435089
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the immune response after local delivery of recombinant adenovirus in murine pancreas and successful strategies for readministration.
McClane SJ; Chirmule N; Burke CV; Raper SE
Hum Gene Ther; 1997 Dec; 8(18):2207-16. PubMed ID: 9449374
[TBL] [Abstract][Full Text] [Related]
9. Elimination of innate immune responses and liver inflammation by PEGylation of adenoviral vectors and methylprednisolone.
De Geest B; Snoeys J; Van Linthout S; Lievens J; Collen D
Hum Gene Ther; 2005 Dec; 16(12):1439-51. PubMed ID: 16390275
[TBL] [Abstract][Full Text] [Related]
10. Improved vascular gene transfer with a helper-dependent adenoviral vector.
Wen S; Graf S; Massey PG; Dichek DA
Circulation; 2004 Sep; 110(11):1484-91. PubMed ID: 15326058
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses.
Mok H; Palmer DJ; Ng P; Barry MA
Mol Ther; 2005 Jan; 11(1):66-79. PubMed ID: 15585407
[TBL] [Abstract][Full Text] [Related]
12. The role of capsid-endothelial interactions in the innate immune response to adenovirus vectors.
Liu Q; Zaiss AK; Colarusso P; Patel K; Haljan G; Wickham TJ; Muruve DA
Hum Gene Ther; 2003 May; 14(7):627-43. PubMed ID: 12804145
[TBL] [Abstract][Full Text] [Related]
13. Biology of E1-deleted adenovirus vectors in nonhuman primate muscle.
Zoltick PW; Chirmule N; Schnell MA; Gao GP; Hughes JV; Wilson JM
J Virol; 2001 Jun; 75(11):5222-9. PubMed ID: 11333904
[TBL] [Abstract][Full Text] [Related]
14. Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectors.
Imler JL; Chartier C; Dreyer D; Dieterle A; Sainte-Marie M; Faure T; Pavirani A; Mehtali M
Gene Ther; 1996 Jan; 3(1):75-84. PubMed ID: 8929914
[TBL] [Abstract][Full Text] [Related]
15. Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1-deleted adenoviruses.
Engelhardt JF; Yang Y; Stratford-Perricaudet LD; Allen ED; Kozarsky K; Perricaudet M; Yankaskas JR; Wilson JM
Nat Genet; 1993 May; 4(1):27-34. PubMed ID: 7685651
[TBL] [Abstract][Full Text] [Related]
16. Trans complementation of an E1A-deleted adenovirus with codelivered E1A sequences to make recombinant adenoviral producer cells.
Goldsmith KT; Curiel DT; Engler JA; Garver RI
Hum Gene Ther; 1994 Nov; 5(11):1341-8. PubMed ID: 7893805
[TBL] [Abstract][Full Text] [Related]
17. Efficient adenoviral vector-directed expression of a foreign gene to neurons and sustentacular cells in the mouse olfactory neuroepithelium.
Holtmaat AJ; Hermens WT; Oestreicher AB; Gispen WH; Kaplitt MG; Verhaagen J
Brain Res Mol Brain Res; 1996 Sep; 41(1-2):148-56. PubMed ID: 8883946
[TBL] [Abstract][Full Text] [Related]
18. Readministration of helper-dependent adenoviral vectors to mouse airway mediated via transient immunosuppression.
Cao H; Yang T; Li XF; Wu J; Duan C; Coates AL; Hu J
Gene Ther; 2011 Feb; 18(2):173-81. PubMed ID: 20882053
[TBL] [Abstract][Full Text] [Related]
19. Effect of intratracheal adenoviral vector administration on lung development in newborn rats.
Waszak P; Franco-Montoya ML; Jacob MP; Deprez I; Levame M; Lafuma C; Harf A; Delacourt C
Hum Gene Ther; 2002 Oct; 13(15):1873-85. PubMed ID: 12396619
[TBL] [Abstract][Full Text] [Related]
20. Protease-deleted adenovirus vectors and complementing cell lines: potential applications of single-round replication mutants for vaccination and gene therapy.
Oualikene W; Lamoureux L; Weber JM; Massie B
Hum Gene Ther; 2000 Jun; 11(9):1341-53. PubMed ID: 10890743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
